CoChat

Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer’s pathology

Open access
Therriault, Joseph, Ashton, Nicholas James, Pola, Ilaria, Triana-Baltzer, Gallen, Brum, Wagner Scheeren, Di Molfetta, Guglielmo, Arslan, Burak, Rahmouni, Nesrine, Tissot, Cecile, Servaes, Stijn, Stevenson, Jenna, Macedo, Arthur Cassa, Pascoal, Tharick Ali, Kolb, Hartmuth Christian, Jeromin, Andreas, Blennow, Kaj, Zetterberg, Henrik, Rosa-Neto, Pedro, Benedet, Andrea Lessa · 2024 · eBioMedicine
Cited by 84

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Blood-based biomarkers of Alzheimer's disease (AD) have become increasingly important as scalable tools for diagnosis and determining clinical trial eligibility. P-tau217 is the most promising due to its excellent sensitivity and specificity for AD-related pathological changes. METHODS: We compared the performance of two commercially available plasma p-tau217 assays (ALZpath p-tau217 and Janssen p-tau217+) in 294 individuals cross-sectionally. Correlations with amyloid PET and tau PET were assessed, and Receiver Operating Characteristic (ROC) analyses evaluated both p-tau217 assays for identifying AD pathology. FINDINGS: Both plasma p-tau217 assays were strongly associated with amyloid and tau PET. Furthermore, both plasma p-tau217 assays identified individuals with AD vs other neurodegenerative diseases (ALZpath AUC = 0.95; Janssen AUC = 0.96). Additionally, plasma p-tau217 concentrations rose with AD severity and their annual changes correlated with tau PET annual change. INTERPRETATION: Both p-tau217 assays had excellent diagnostic performance for AD. Our study supports the future clinical use of commercially-available assays for p-tau217. FUNDING: This research is supported by the Weston Brain Institute, Canadian Institutes of Health Research (CIHR), Canadian Consortium on Neurodegeneration in Aging, the Alzheimer's Association, Brain Canada Foundation, the Fonds de Recherche du Québec - Santé and the Colin J. Adair Charitable Foundation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ebiom.2024.105046

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

See all 84

Metadata

Authors
Therriault, J., Ashton, N. J., Pola, I., Triana-Baltzer, G., Brum, W. S., Di Molfetta, G., Arslan, B., Rahmouni, N., Tissot, C., Servaes, S., Stevenson, J., Macedo, A. C., Pascoal, T. A., Kolb, H. C., Jeromin, A., Blennow, K., Zetterberg, H., Rosa-Neto, P., & Benedet, A. L.
Venue
eBioMedicine
Publisher
Elsevier BV
Published
2024-04
Volume
102
Pages
105046
ISSN
2352-3964 (ISSN-L)
OpenAlex
W4392672292
Cited by
84
References
26
FWCI
22.61
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer’s pathology. https://app.cochat.ai/papers/10.1016/j.ebiom.2024.105046
The paper
Therriault, J., Ashton, N. J., Pola, I., Triana-Baltzer, G., Brum, W. S., Di Molfetta, G., Arslan, B., Rahmouni, N., Tissot, C., Servaes, S., Stevenson, J., Macedo, A. C., Pascoal, T. A., Kolb, H. C., Jeromin, A., Blennow, K., Zetterberg, H., Rosa-Neto, P., & Benedet, A. L. (2024). Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer’s pathology. eBioMedicine. https://doi.org/10.1016/j.ebiom.2024.105046

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.